Related Experiment Video

Updated: Mar 22, 2026

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
10:40

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

26.6K

Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus

Marko Zivcec1, Florine E M Scholte2, Christina F Spiropoulou3

  • 1Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. mzivcec@cdc.gov.

Viruses
|April 26, 2016
PubMed

Insights

Crimean-Congo hemorrhagic fever virus (CCHFV) causes severe illness, with limited treatment options. Recent molecular research advances CCHFV understanding, paving the way for future therapeutic strategies against this tick-borne pathogen.

Area of Science:

  • Virology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Crimean-Congo hemorrhagic fever virus (CCHFV) is a significant tick-borne pathogen responsible for high rates of human morbidity and mortality.
  • Current therapeutic interventions, including vaccines and antivirals for CCHFV, exhibit limited and debated efficacy.
  • Comprehensive understanding of CCHFV and related nairoviruses' pathology and molecular mechanisms is still developing.

Purpose of the Study:

  • To review recent molecular advancements in CCHFV research.
  • To highlight progress in understanding CCHFV replication and pathogenesis.
  • To offer perspectives for future research directions in CCHFV and nairovirus studies.

Main Methods:

  • Literature review focusing on molecular CCHFV research.
  • Analysis of recent findings on CCHFV replication and pathogenesis.
  • Synthesis of current knowledge and identification of research gaps.

Main Results:

  • Significant progress has been achieved in understanding CCHFV molecular biology over the last decade.
  • Recent research has elucidated key aspects of CCHFV replication and disease-causing mechanisms.
  • The review consolidates current molecular insights into CCHFV.

Conclusions:

  • Continued molecular research is crucial for developing effective CCHFV treatments.
  • Understanding nairovirus molecular mechanisms is essential for combating tick-borne hemorrhagic fevers.
  • Future research should build upon recent molecular advances to address CCHFV challenges.

Keywords:
Crimean-Congo hemorrhagic feverpathogenesisreverse geneticstick-borne virusviral hemorrhagic fever

More Related Videos

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment08:34

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment

Published on: March 2, 2016

10.2K
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.1K

Related Concept Videos

Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
3
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.7K